PRGS vs. AYTU
PRGS (Progress Software Corporation) and AYTU (Aytu BioPharma, Inc.) are both stocks. PRGS operates in Software - Application (Technology), while AYTU operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, PRGS returned -7.35%/yr vs -54.38%/yr for AYTU. At a 0.13 correlation, their price movements are largely independent.
Performance
PRGS vs. AYTU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PRGS achieves a -26.75% return, which is significantly lower than AYTU's -17.31% return.
PRGS
- 1D
- -0.38%
- 1M
- 17.43%
- YTD
- -26.75%
- 6M
- -29.75%
- 1Y
- -49.74%
- 3Y*
- -19.45%
- 5Y*
- -7.35%
- 10Y*
- 3.19%
AYTU
- 1D
- -1.83%
- 1M
- -1.83%
- YTD
- -17.31%
- 6M
- -6.52%
- 1Y
- 10.26%
- 3Y*
- 6.50%
- 5Y*
- -54.38%
- 10Y*
- —
PRGS vs. AYTU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PRGS Progress Software Corporation | -26.75% | -34.06% | 21.16% | 8.94% | 6.05% | 8.44% | 10.64% | 18.95% | -15.41% | 54.35% |
AYTU Aytu BioPharma, Inc. | -17.31% | 52.94% | -40.14% | -24.87% | -86.00% | -77.42% | -38.35% | 22.41% | -98.22% | -89.38% |
Correlation
The correlation between PRGS and AYTU is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2017 | 0.13 |
Fundamentals
PRGS:
$1.34B
AYTU:
$22.60M
PRGS:
$1.95
AYTU:
-$2.91
PRGS:
1.39
AYTU:
0.44
PRGS:
2.70
AYTU:
0.64
PRGS:
$987.62M
AYTU:
$56.60M
PRGS:
$802.40M
AYTU:
$36.14M
PRGS:
$136.06M
AYTU:
-$27.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRGS vs. AYTU — Risk / Return Rank
PRGS
AYTU
PRGS vs. AYTU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Progress Software Corporation (PRGS) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRGS | AYTU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.22 | ||
| Sortino ratioReturn per unit of downside risk | -2.19 | ||
| Omega ratioGain probability vs. loss probability | 0.81 | 1.08 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.82 | 0.29 | -1.11 |
| Martin ratioReturn relative to average drawdown | -1.30 | 0.68 | -1.97 |
Loading charts...
Drawdowns
PRGS vs. AYTU - Drawdown Comparison
The maximum PRGS drawdown since its inception was -67.33%, smaller than the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for PRGS and AYTU.
Loading charts...
Drawdown Indicators
| PRGS | AYTU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.33% | -100.00% | +32.67% |
Max Drawdown (1Y)Largest decline over 1 year | -61.14% | -35.47% | -25.67% |
Max Drawdown (3Y)Largest decline over 3 years | -64.10% | -70.24% | +6.14% |
Max Drawdown (5Y)Largest decline over 5 years | -64.10% | -99.12% | +35.02% |
Max Drawdown (10Y)Largest decline over 10 years | -64.10% | — | — |
Current DrawdownCurrent decline from peak | -54.97% | -100.00% | +45.03% |
Average DrawdownAverage peak-to-trough decline | -23.57% | -95.26% | +71.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 38.81% | 15.16% | +23.65% |
Volatility
PRGS vs. AYTU - Volatility Comparison
Progress Software Corporation (PRGS) has a higher volatility of 14.81% compared to Aytu BioPharma, Inc. (AYTU) at 12.94%. This indicates that PRGS's price experiences larger fluctuations and is considered to be riskier than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRGS | AYTU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.81% | 12.94% | +1.87% |
Volatility (6M)Calculated over the trailing 6-month period | 41.69% | 33.57% | +8.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.89% | 54.47% | -5.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.42% | 85.63% | -52.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.17% | 188.01% | -154.84% |
Dividends
PRGS vs. AYTU - Dividend Comparison
Neither PRGS nor AYTU has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
AYTU Aytu BioPharma, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PRGS Progress Software Corporation | 0.00% | 0.00% | 0.81% | 1.29% | 1.39% | 1.45% | 1.48% | 1.52% | 1.62% | 1.21% | 0.39% |
Financials
PRGS vs. AYTU - Financials Comparison
This section allows you to compare key financial metrics between Progress Software Corporation and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PRGS vs. AYTU - Profitability Comparison
PRGS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Progress Software Corporation reported a gross profit of 203.94M and revenue of 247.80M. Therefore, the gross margin over that period was 82.3%.
AYTU - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a gross profit of 7.60M and revenue of 12.41M. Therefore, the gross margin over that period was 61.2%.
PRGS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Progress Software Corporation reported an operating income of 46.47M and revenue of 247.80M, resulting in an operating margin of 18.8%.
AYTU - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported an operating income of -4.06M and revenue of 12.41M, resulting in an operating margin of -32.8%.
PRGS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Progress Software Corporation reported a net income of 22.81M and revenue of 247.80M, resulting in a net margin of 9.2%.
AYTU - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a net income of -5.62M and revenue of 12.41M, resulting in a net margin of -45.3%.
Frequently Asked Questions
PRGS and AYTU have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRGS has higher volatility (14.81%) compared to AYTU (12.94%). In terms of maximum drawdown, PRGS dropped -67.33% vs AYTU's -100.00%.
AYTU currently has the higher Sharpe Ratio (0.19 vs -1.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRGS and AYTU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer